ahlam1399
09-15-2016, 05:00 PM
AcelRx?s opioid painkiller succeeds in key study
(Reuters) - AcelRx Pharmaceuticals Inc said its experimental opioid painkiller was well tolerated in post-operative patients, including those with organ impairment and the elderly, in a late-stage study.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=h1h8rIYzpY0:WgVl8xCmlhQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=h1h8rIYzpY0:WgVl8xCmlhQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=h1h8rIYzpY0:WgVl8xCmlhQ:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=h1h8rIYzpY0:WgVl8xCmlhQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=h1h8rIYzpY0:WgVl8xCmlhQ:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/h1h8rIYzpY0
(Reuters) - AcelRx Pharmaceuticals Inc said its experimental opioid painkiller was well tolerated in post-operative patients, including those with organ impairment and the elderly, in a late-stage study.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=h1h8rIYzpY0:WgVl8xCmlhQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=h1h8rIYzpY0:WgVl8xCmlhQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=h1h8rIYzpY0:WgVl8xCmlhQ:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=h1h8rIYzpY0:WgVl8xCmlhQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=h1h8rIYzpY0:WgVl8xCmlhQ:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/h1h8rIYzpY0